Zurueck zur Suche

Reporte zur Charge U007686

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

13Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 OK 2 TX 2 CT 1 OH 1 CA 1 AZ 1 ID 1 PR 1 VA 1

VAERS 2211437

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

schwer
Staat
CT
Alter
1,0
Geschlecht
M
Eingang
01.04.2022
Impfdatum
22.03.2022
Beginn
30.03.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyskinesia Immunisation reaction Pyrexia Rash Rash erythematous Rash papular Seizure like phenomena Unresponsive to stimuli

Symptomtext

Patient received MMR vaccine on 3/22/22 by LPN. He tolerated it well. On March 30, 2022 father called at 10:37am stating patient had a low grade temperature of 99.0 F that day and day before. Advised parents to monitor temperature and could give Tylenol or motrin if temp rose above 100.4. He was eating and drinking well, per dad and having wet diapers. Dad verbalized understanding and would call back as needed. Dad called back that day at 4:12pm stating he had an unresponsive incident and some odd leg movements. It was advised at that time for him to be evaluated at ED. Parents agreed and brought him to the ED right away. Patient was seen at ED for seizure activity, fever and rash on patient's trunk. He was evaluated and then discharged home. Diagnosed with possible seizure activity related to fever. Patient was seen today by Dr. for follow up appointment. Patient was happy and doing well. He is afebrile, no seizure acitivity noticed, but continues to have small pin point, raised red rash on abdomen and back. Rash believed to be related to MMR vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Triamcinolone Acetonide 0.1% external ointment.
Allergien
Rice and Oatmeal allergy
Vorherige Impfungen
-

VAERS 2639693

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

mild
Staat
OH
Alter
1,6
Geschlecht
M
Eingang
01.06.2023
Impfdatum
11.07.2022
Beginn
18.07.2022
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Post vaccination fever

Symptomtext

Postvaccination fever on 2022-07-18.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Post vaccination fever
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Acute atopic conjunctivitis, bilateral; Encounter for routine child health examination NOS; Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism; Encounter for screening for disorder due to exposure to contaminants; Need for immunization against single bacterial diseases
Vorgeschichte
-
Andere Medikamente
POLY-VI-SOL/IRON 11 MG/ML ORAL SOLN
Allergien
-
Vorherige Impfungen
-

VAERS 2223589

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

mild
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
30.03.2022
Beginn
31.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site vesicles

Symptomtext

Pt developed pain and erythema in the Right leg. Mother called to report on 6 days after administration. Pictures that mother provided showed 3-4 vesicles around the injection site. Pt came to the office the day after mother contacted us and the vesicles had crusted over less than 24 hours after the picture. Per Mother patient reported pain in both legs starting the day after she received vaccinations, to the point it was difficult to put on pants, for over a week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2644251

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
12.06.2023
Impfdatum
14.04.2023
Beginn
14.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; Caller reported expired MMR II was administered.; This spontaneous report was received from an office manager and refers to a female patient of unknown age. No information on patient's medical history, current conditions and concomitant medications was provided On 14-APR-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (albumin status: rHA) lot # U007686 and expiration date 09-MAR-2023, 0.5 milliliter, subcutaneously for prophylaxis (dose number was not provided) (expired product and no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643868

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
12.06.2023
Impfdatum
14.04.2023
Beginn
14.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; expired MMR II was administered; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 14-APR-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 0.5 mL, subcutaneously (SQ), Albumin status rHA lot # U007686 with expiration date 09-MAR-2023, for prophylaxis (strength was not provided). No additional adverse event (AE) was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627922

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u007686

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
08.05.2023
Impfdatum
19.04.2023
Beginn
20.04.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Confirmed no other AE occurred; An expired dose of MMRIII was administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported. On 19-APR-2023, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot number w005208 has been determined to be valid for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date reported and established as 14-FEB-2024), and on 20-APR-2023, the patient was vaccinated with the first dose of an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (expired product administered) subcutaneous injection (lot number u007686 has been determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported and established as 09-MAR-2023), both administered for prophylaxis (strength, dose, frequency and anatomical site of administration were not provided).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2622629

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
CA
Alter
28,0
Geschlecht
F
Eingang
27.04.2023
Impfdatum
27.03.2023
Beginn
27.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AE.; she went to a pharmacy to report vaccine on 28-MAR-2023; A HCP called and reported an expired dose of MMR II was given to a patient on 3/27/2023. No adverse effects were reported. No additional information was provided to further clarify any other details. No additional AE. No PQC.; This spontaneous report was received from a nurse and referred to a 28-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included sterile diluent and varicella virus vaccine live (oka/merck) (VARIVAX). On 27-MAR-2023, the patient was vaccinated with first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) recombinant human albumin (rHA) injection (0.5 milliliter/once, lot #U007686, expiration date: 09-MAR-2023 (upon internal validation), anatomical location: right arm, strength and route of administration were not provided) for prophylaxis, which was purchased by private funds (Expired product administered). Provider notified manager and patient and patient understand this event. Provider recommended patient to repeat vaccine in 28 days. On 28-MAR-2023, the patient went to pharmacy to repeat measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (dose, lot, expiration date, anatomical location, strength and route of administration were not provided) for prophylaxis (Inappropriate schedule of product administration). No additional adverse event (AE) (no adverse event). .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT; VARIVAX
Allergien
-
Vorherige Impfungen
-

VAERS 2619179

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
TX
Alter
44,0
Geschlecht
F
Eingang
21.04.2023
Impfdatum
20.04.2023
Beginn
20.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Patient was given expired MMR. Vaccine expired on 03/09/2023. Patient did not have any adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
HLP
Andere Medikamente
Singulair, Iron ,Atorvastatin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2607418

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
AZ
Alter
45,0
Geschlecht
F
Eingang
31.03.2023
Impfdatum
27.03.2023
Beginn
27.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

The vaccines was given with an expired date. It was expired on March 9, 2023. FNP informed patient on March 30, 2023 of the mistake that had occured on March 27,2023. Patient understood and was not concerned. She did not have any symptoms or signs of any reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Ciprofloxacin- Hives/Skin Rash, lip swelling
Vorherige Impfungen
-

VAERS 2422805

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
ID
Alter
63,0
Geschlecht
F
Eingang
29.08.2022
Impfdatum
29.08.2022
Beginn
29.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

The nurse was going to administer a yellow fever and mmr vaccine to client and the same vaccines to client's spouse. The nurse administered the client's mmr dose in the left arm and was supposed to administer the YF dose in the right arm and accidentally grabbed the spouse's mmr dose and administered it instead of the YF dose. Nurse explained the mix up to the client and explained to look for any out of the norm symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2313408

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
MI
Alter
4,0
Geschlecht
M
Eingang
08.06.2022
Impfdatum
08.06.2022
Beginn
08.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

The child rolled over while recieving their MMR vaccine. Less than 0.1ml was not injected, next time we will have an additional MA help hold the child.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2302893

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
PR
Alter
-
Geschlecht
U
Eingang
31.05.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs reported; one dose of improperly stored MMR II was administered to a patient on 24May2022; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Information about patient's pertinent medical history, concomitant medications, concurrent conditions and drug reactions/ allergies was not provided. On 24-MAY-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin, rHA) (M-M-R II), lot number: U007686, expiration date: 09-MAR-2023 (dose, dose number and route of administration was not provided) for prophylaxis (product storage error). No additional adverse events (AEs) were reported (no adverse event). No product quality complaint (PQC). The administered dose of the vaccine experienced a temperature excursion of 13.4 degrees Celsius for 8 hours. There were no previous reported temperature excursions. It was unknown if a digital data logger was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2270763

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U007686

gering
Staat
VA
Alter
2,0
Geschlecht
M
Eingang
11.05.2022
Impfdatum
10.05.2022
Beginn
10.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Pentacel was given too early. Patient needed a plain Polio and a plain Haemophilus Influenzae.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nkda
Vorherige Impfungen
-